Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
- 1 September 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 234 (1) , 47-50
- https://doi.org/10.1016/s0304-3940(97)00663-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of Different Schedules of MPTP Administration on Dopaminergic Neurodegeneration in MiceExperimental Neurology, 1997
- Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental ParkinsonismNeuroscience, 1997
- A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkeyBrain Research, 1997
- Presymptomatic revelation of experimental ParkinsonismNeuroReport, 1997
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Pattern of brain destruction in Parkinson's and Alzheimer's diseasesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graftBrain Research, 1991
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960